Heterocyclic spiro compounds and methods of use thereof for the treatment of cancer

Compounds having activity as inhibitors of G12C mutant KRAS protein are provided. The compounds have the following structure (I): or a pharmaceutically acceptable salt, stereoisomer, isotopic form or prodrug thereof, wherein R

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LIU, Yuan, BORUM, Alana K, LI, Liansheng, FENG, Jun, LIU, Yi, WU, Tao, WANG, Yi, REN, Pingda
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Compounds having activity as inhibitors of G12C mutant KRAS protein are provided. The compounds have the following structure (I): or a pharmaceutically acceptable salt, stereoisomer, isotopic form or prodrug thereof, wherein R